FLUORESCITE

This brand name is authorized in Canada, Estonia, Hong Kong SAR China, Japan, New Zealand, Turkey, United States.

Active ingredients

The drug FLUORESCITE contains one active pharmaceutical ingredient (API):

1	Fluorescein UNII 93X55PE38X - FLUORESCEIN SODIUM
	Fluorescein is a fluorochrome used in medicine as a diagnostic stain. Fluorescein is used to make the blood vessels of the ocular fundus visible (angiography of the retina and choroid).
	Read more about Fluorescein

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FLUORESCITE Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V04CX	Other diagnostic agents	V Various → V04 Diagnostic agents → V04C Other diagnostic agents
Discover more medicines within V04CX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00505005
EE	Ravimiamet	1258141
HK	Department of Health Drug Office	59383
JP	医薬品医療機器総合機構	7290402A2035
NZ	Medicines and Medical Devices Safety Authority	6221
TR	İlaç ve Tıbbi Cihaz Kurumu	8699760751394, 8699760751400
US	FDA, National Drug Code	0065-0092